Anastrozole-Products-Jinan Xinnuo Pharmaceutical Technology Co., Ltd.

Description

Anastrozole (INN) (marketed under the trade name Arimidex by AstraZeneca) is a non-steroidal aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastasis in both pre and post-menopausal women. The severity of breast cancer can be increased by estrogen, as sex hormones cause hyperplasia, and differentiation at estrogen receptor sites. Anastrozole works by inhibiting the synthesis of estrogen. The patent on Arimidex by AstraZeneca expired June 2010.

It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.

Basic Info

Chemical Name	anastrozole
Synonyms	ICI-D-1033;Anastrozole;ZD-1033;Anastrol;1,3-benzenediacetonitrile;ANASTRAZOLE;2,2'-(5-((1H-1,2,4-Triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile);4-Triazol-1-ylmethyl)-1;Anastrolozole;Anatrozole;Anastrozol;ARIMIDEX;
CAS No.	120511-73-1
Molecular Formula	C17H19N5
Molecular Weight	293.36600
PSA	78.29000
LogP	2.92876

Properties

Appearance & Physical State	crystalline solid
Density	1.08 g/cm3
Boiling Point	469.7ºC at 760 mmHg
Melting Point	81-82ºC
Refractive Index	1.791
Storage Condition	Store in original container in a cool dark place.

Safety Info

Hazard Class	6.1(b)
Safety Statements	S26; S37/39
HS Code	2942090090
Packing Group	III
RIDADR	3249
Risk Statements	R36/37/38
Hazard Codes	Xi

Company Profile

Jinan Xinnuo Pharmaceutical Technology Co., Ltd. is a high-tech enterprise specializing in the production of pharmaceutical intermediates. The company has been engaged in the research, development and production of chemical intermediates for more than 10 years. It integrates research, development, production, import and export trade, strong technical force, advanced testing methods, strong research and development capabilities and superb synthetic technology. It is an incubator of Jinan Pharmaceutical Valley. Committed to gout, nutrition, anti-cancer, anti-depression, anti-age dementia and drug synthesis in the cardiovascular and cerebrovascular fields. The products are mainly exported, and the products are exported to more than 40 countries and regions such as Southeast Asia, South America and Eastern Europe.

The company has a complete quality assurance system and strong scientific research and innovation strength. Every year, new market-oriented and high-tech synthetic drugs are launched. We are willing to provide you with quality products and competitive prices. Efficient service.